{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,6]],"date-time":"2025-11-06T12:32:11Z","timestamp":1762432331218},"reference-count":29,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2023,2,2]],"date-time":"2023-02-02T00:00:00Z","timestamp":1675296000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2023,2,2]],"date-time":"2023-02-02T00:00:00Z","timestamp":1675296000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"name":"the Foundation of CSCO-Shiyao","award":["Y-SY201901-0068"],"award-info":[{"award-number":["Y-SY201901-0068"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Strahlenther Onkol"],"published-print":{"date-parts":[[2023,3]]},"DOI":"10.1007\/s00066-022-02042-w","type":"journal-article","created":{"date-parts":[[2023,2,2]],"date-time":"2023-02-02T12:07:01Z","timestamp":1675339621000},"page":"313-321","update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Chemoradiotherapy for untreated Masaoka\u2013Koga stage IVB thymic carcinoma: a\u00a0single-center retrospective study"],"prefix":"10.1007","volume":"199","author":[{"given":"Jia-nan","family":"Jin","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yue","family":"Hao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wen-xian","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shi-yan","family":"Wu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Peng","family":"Yue","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zheng-bo","family":"Song","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2023,2,2]]},"reference":[{"issue":"1","key":"2042_CR1","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1016\/j.ejca.2007.11.004","volume":"44","author":"WK de Jong","year":"2008","unstructured":"de Jong\u00a0WK, Blaauwgeers\u00a0JL, Schaapveld\u00a0M, Timens\u00a0W, Klinkenberg\u00a0TJ, Groen\u00a0HJ (2008) Thymic epithelial tumours: a\u00a0population-based study of the incidence, diagnostic procedures and therapy. Eur J Cancer 44(1):123\u2013130. https:\/\/doi.org\/10.1016\/j.ejca.2007.11.004","journal-title":"Eur J Cancer"},{"issue":"6","key":"2042_CR2","doi-asserted-by":"publisher","first-page":"827","DOI":"10.1016\/j.jtho.2022.02.001","volume":"17","author":"DW Shin","year":"2022","unstructured":"Shin\u00a0DW, Cho\u00a0JH, Ha\u00a0J, Jung\u00a0KW (2022) Trends in incidence and survival of patients with thymic epithelial tumor in a\u00a0high-incidence asian country: analysis of the Korean central cancer registry 1999 to 2017. J\u00a0Thorac Oncol 17(6):827\u2013837. https:\/\/doi.org\/10.1016\/j.jtho.2022.02.001","journal-title":"J Thorac Oncol"},{"issue":"11","key":"2042_CR3","doi-asserted-by":"publisher","first-page":"2485","DOI":"10.1002\/1097-0142(19811201)48:11<2485::AID-CNCR2820481123>3.0.CO;2-R","volume":"48","author":"A Masaoka","year":"1981","unstructured":"Masaoka\u00a0A, Monden\u00a0Y, Nakahara\u00a0K, Tanioka\u00a0T (1981) Follow-up study of thymomas with special reference to their clinical stages. Cancer 48(11):2485\u20132492. https:\/\/doi.org\/10.1002\/1097-0142(19811201)48:11\u30082485::aid-cncr2820481123\u30093.0.co;2\u2011r","journal-title":"Cancer"},{"issue":"5","key":"2042_CR4","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1111\/j.1440-1827.1994.tb02936.x","volume":"44","author":"K Koga","year":"1994","unstructured":"Koga\u00a0K, Matsuno\u00a0Y, Noguchi\u00a0M, Mukai\u00a0K, Asamura\u00a0H, Goya\u00a0T, Shimosato\u00a0Y (1994) A review of 79 thymomas: modification of staging system and reappraisal of conventional division into invasive and non-invasive thymoma. Pathol Int 44(5):359\u2013367. https:\/\/doi.org\/10.1111\/j.1440-1827.1994.tb02936.x","journal-title":"Pathol Int"},{"issue":"2","key":"2042_CR5","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1097\/COC.0000000000000024","volume":"39","author":"A Modh","year":"2016","unstructured":"Modh\u00a0A, Rimner\u00a0A, Allen\u00a0PK, Greenfield\u00a0B, Marom\u00a0EM, Rice\u00a0D, Huang\u00a0J, Rosenzweig\u00a0KE, Komaki\u00a0R, Gomez\u00a0DR (2016) Treatment modalities and outcomes in patients with advanced invasive thymoma or thymic carcinoma: a retrospective multicenter study. Am J Clin Oncol 39(2):120\u2013125. https:\/\/doi.org\/10.1097\/COC.0000000000000024","journal-title":"Am J Clin Oncol"},{"issue":"4","key":"2042_CR6","doi-asserted-by":"publisher","first-page":"819","DOI":"10.1016\/j.ejcts.2009.11.001","volume":"37","author":"G Cardillo","year":"2010","unstructured":"Cardillo\u00a0G, Carleo\u00a0F, Giunti\u00a0R, Lopergolo\u00a0MG, Salvadori\u00a0L, De Massimi\u00a0AR, Petrella\u00a0L, Martelli\u00a0M (2010) Predictors of survival in patients with locally advanced thymoma and thymic carcinoma (Masaoka stages III and IVa). Eur J Cardiothorac Surg 37(4):819\u2013823. https:\/\/doi.org\/10.1016\/j.ejcts.2009.11.001","journal-title":"Eur J Cardiothorac Surg"},{"issue":"5","key":"2042_CR7","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1177\/0300891620967980","volume":"107","author":"Y Zhai","year":"2021","unstructured":"Zhai\u00a0Y, Chen\u00a0D, Gao\u00a0Y, Hui\u00a0Z, Xue\u00a0L, Zhou\u00a0Z, Luo\u00a0Y, Xiao\u00a0Z, Feng\u00a0Q (2021) Role of modern neoadjuvant chemoradiotherapy in locally advanced thymic epithelial neoplasms. Tumori 107(5):407\u2013415. https:\/\/doi.org\/10.1177\/0300891620967980","journal-title":"Tumori"},{"issue":"11","key":"2042_CR8","doi-asserted-by":"publisher","first-page":"2081","DOI":"10.1111\/1759-7714.13181","volume":"10","author":"X Yang","year":"2019","unstructured":"Yang\u00a0X, Zhuo\u00a0M, Shi\u00a0A, Yang\u00a0S, Wang\u00a0Z, Wu\u00a0M, An\u00a0T, Wang\u00a0Y, Li\u00a0J, Zhong\u00a0J, Chen\u00a0H, Jia\u00a0B, Dong\u00a0Z, Zhao\u00a0J (2019) Optimal first-line treatment for advanced thymic carcinoma. Thorac Cancer 10(11):2081\u20132087. https:\/\/doi.org\/10.1111\/1759-7714.13181","journal-title":"Thorac Cancer"},{"issue":"3","key":"2042_CR9","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1097\/JTO.0b013e3181653c71","volume":"3","author":"M Yano","year":"2008","unstructured":"Yano\u00a0M, Sasaki\u00a0H, Yokoyama\u00a0T, Yukiue\u00a0H, Kawano\u00a0O, Suzuki\u00a0S, Fujii\u00a0Y (2008) Thymic carcinoma: 30\u00a0cases at a\u00a0single institution. J\u00a0Thorac Oncol 3(3):265\u2013269. https:\/\/doi.org\/10.1097\/JTO.0b013e3181653c71","journal-title":"J Thorac Oncol"},{"issue":"3","key":"2042_CR10","doi-asserted-by":"publisher","first-page":"659","DOI":"10.21037\/jtd.2019.12.111","volume":"12","author":"C Ye","year":"2020","unstructured":"Ye\u00a0C, Bao\u00a0M, Li\u00a0H, Liu\u00a0X, Jiang\u00a0G, Wang\u00a0W (2020) Surgery in Masaoka stage IV thymic carcinoma: a\u00a0propensity-matched study based on the SEER database. J\u00a0Thorac Dis 12(3):659\u2013671. https:\/\/doi.org\/10.21037\/jtd.2019.12.111","journal-title":"J Thorac Dis"},{"issue":"1","key":"2042_CR11","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1186\/s12885-017-3228-2","volume":"17","author":"Y Yang","year":"2017","unstructured":"Yang\u00a0Y, Fan\u00a0XW, Wang\u00a0HB, Xu\u00a0Y, Li\u00a0DD, Wu\u00a0KL (2017) Stage IVb thymic carcinoma: patients with lymph node metastases have better prognoses than those with hematogenous metastases. BMC Cancer 17(1):217. https:\/\/doi.org\/10.1186\/s12885-017-3228-2","journal-title":"BMC Cancer"},{"issue":"15","key":"2042_CR12","doi-asserted-by":"publisher","first-page":"2060","DOI":"10.1200\/JCO.2010.32.9607","volume":"29","author":"GL Lemma","year":"2011","unstructured":"Lemma\u00a0GL, Lee\u00a0JW, Aisner\u00a0SC, Langer\u00a0CJ, Tester\u00a0WJ, Johnson\u00a0DH, Loehrer\u00a0PJ Sr (2011) Phase II study of carboplatin and paclitaxel in advanced thymoma and thymic carcinoma. J\u00a0Clin Oncol 29(15):2060\u20132065. https:\/\/doi.org\/10.1200\/JCO.2010.32.9607","journal-title":"J Clin Oncol"},{"issue":"12","key":"2042_CR13","doi-asserted-by":"publisher","first-page":"722","DOI":"10.1093\/jjco\/hyh141","volume":"34","author":"T Nonaka","year":"2004","unstructured":"Nonaka\u00a0T, Tamaki\u00a0Y, Higuchi\u00a0K, Katoh\u00a0H, Nakahashi\u00a0M, Horikoshi\u00a0H, Takahashi\u00a0K, Minato\u00a0K, Sugihara\u00a0S, Kojima\u00a0M (2004) The role of radiotherapy for thymic carcinoma. Jpn J Clin Oncol 34(12):722\u2013726. https:\/\/doi.org\/10.1093\/jjco\/hyh141","journal-title":"Jpn J Clin Oncol"},{"issue":"10","key":"2042_CR14","doi-asserted-by":"publisher","first-page":"1383","DOI":"10.1097\/JTO.0000000000000654","volume":"10","author":"A Marx","year":"2015","unstructured":"Marx\u00a0A, Chan\u00a0JK, Coindre\u00a0JM, Detterbeck\u00a0F, Girard\u00a0N, Harris\u00a0NL, Jaffe\u00a0ES, Kurrer\u00a0MO, Marom\u00a0EM, Moreira\u00a0AL, Mukai\u00a0K, Orazi\u00a0A, Str\u00f6bel\u00a0P (2015) The 2015 World Health Organization classification of tumors of the thymus: continuity and changes. J\u00a0Thorac Oncol 10(10):1383\u20131395. https:\/\/doi.org\/10.1097\/JTO.0000000000000654","journal-title":"J Thorac Oncol"},{"issue":"5","key":"2042_CR15","doi-asserted-by":"publisher","first-page":"1341","DOI":"10.1016\/0360-3016(95)00060-C","volume":"31","author":"JD Cox","year":"1995","unstructured":"Cox\u00a0JD, Stetz\u00a0J, Pajak\u00a0TF (1995) Toxicity criteria of the Radiation Therapy Oncology Group (RTOG) and the European Organization for Research and Treatment of Cancer (EORTC). Int J Radiat Oncol Biol Phys 31(5):1341\u20131346. https:\/\/doi.org\/10.1016\/0360-3016(95)00060-C","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"2","key":"2042_CR16","doi-asserted-by":"publisher","first-page":"363","DOI":"10.1093\/annonc\/mdu541","volume":"26","author":"F Hirai","year":"2015","unstructured":"Hirai\u00a0F, Yamanaka\u00a0T, Taguchi\u00a0K, Daga\u00a0H, Ono\u00a0A, Tanaka\u00a0K, Kogure\u00a0Y, Shimizu\u00a0J, Kimura\u00a0T, Fukuoka\u00a0J, Iwamoto\u00a0Y, Sasaki\u00a0H, Takeda\u00a0K, Seto\u00a0T, Ichinose\u00a0Y, Nakagawa\u00a0K, Nakanishi\u00a0Y (2015) A multicenter phase II study of carboplatin and paclitaxel for advanced thymic carcinoma: WJOG4207L. Ann Oncol 26(2):363\u2013368. https:\/\/doi.org\/10.1093\/annonc\/mdu541","journal-title":"Ann Oncol"},{"issue":"2","key":"2042_CR17","doi-asserted-by":"publisher","first-page":"194","DOI":"10.1016\/j.lungcan.2009.03.031","volume":"67","author":"S Igawa","year":"2010","unstructured":"Igawa\u00a0S, Murakami\u00a0H, Takahashi\u00a0T, Nakamura\u00a0Y, Tsuya\u00a0A, Naito\u00a0T, Kaira\u00a0K, Ono\u00a0A, Shukuya\u00a0T, Tamiya\u00a0A, Endo\u00a0M, Yamamoto\u00a0N (2010) Efficacy of chemotherapy with carboplatin and paclitaxel for unresectable thymic carcinoma. Lung Cancer 67(2):194\u2013197. https:\/\/doi.org\/10.1016\/j.lungcan.2009.03.031","journal-title":"Lung Cancer"},{"issue":"3","key":"2042_CR18","doi-asserted-by":"publisher","first-page":"330","DOI":"10.3389\/fonc.2013.00330","volume":"10","author":"R Komaki","year":"2014","unstructured":"Komaki\u00a0R, Gomez\u00a0DR (2014) Radiotherapy for thymic carcinoma: adjuvant, inductive, and definitive. Front Oncol 10(3):330. https:\/\/doi.org\/10.3389\/fonc.2013.00330","journal-title":"Front Oncol"},{"issue":"2","key":"2042_CR19","doi-asserted-by":"publisher","first-page":"182","DOI":"10.1111\/1759-7714.12305","volume":"7","author":"J Wang","year":"2016","unstructured":"Wang\u00a0J, Ji\u00a0Z, Wang\u00a0X, Liang\u00a0J, Hui\u00a0Z, Lv\u00a0J, Zhou\u00a0Z, Yin\u00a0W, Wang\u00a0L (2016) Radical thoracic radiotherapy may provide favorable outcomes for stage IV non-small cell lung cancer. Thorac Cancer 7(2):182\u2013189. https:\/\/doi.org\/10.1111\/1759-7714.12305","journal-title":"Thorac Cancer"},{"issue":"7","key":"2042_CR20","first-page":"515","volume":"27","author":"YY Chen","year":"2004","unstructured":"Chen\u00a0YY, Huang\u00a0CH, Tang\u00a0Y, Eng\u00a0HL (2004) Concurrent chemoradiotherapy for unresectable thymic carcinoma. Chang Gung Med\u00a0J 27(7):515\u2013522","journal-title":"Chang Gung Med J"},{"issue":"10","key":"2042_CR21","doi-asserted-by":"publisher","first-page":"2924","DOI":"10.1111\/1759-7714.13635","volume":"11","author":"RF Chu","year":"2020","unstructured":"Chu\u00a0RF, Hussien\u00a0A, Li\u00a0QK, Wang\u00a0J, Friedes\u00a0C, Ferro\u00a0A, Hales\u00a0RK, Battafarano\u00a0R, Ettinger\u00a0DS, Voong\u00a0KR (2020) Radiologic response of chemotherapy alone versus radiation and chemotherapy in the treatment of locally-advanced or advanced thymic epithelial tumors. Thorac Cancer 11(10):2924\u20132931. https:\/\/doi.org\/10.1111\/1759-7714.13635","journal-title":"Thorac Cancer"},{"issue":"1","key":"2042_CR22","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1016\/j.ijrobp.2019.12.045","volume":"107","author":"XW Fan","year":"2020","unstructured":"Fan\u00a0XW, Yang\u00a0Y, Wang\u00a0HB, Xu\u00a0Y, Kang\u00a0M, Xie\u00a0LY, Li\u00a0L, Fang\u00a0WT, Zhao\u00a0KL, Chen\u00a0HQ, Xiang\u00a0JQ, Ung\u00a0YC, Wong\u00a0CS, Jiang\u00a0GL, Wu\u00a0KL (2020) Intensity modulated radiation therapy plus etoposide\/cisplatin for patients with limited advanced unresectable thymic epithelial tumors: A prospective phase 2 study. Int J Radiat Oncol Biol Phys 107(1):98\u2013105. https:\/\/doi.org\/10.1016\/j.ijrobp.2019.12.045","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"8","key":"2042_CR23","doi-asserted-by":"publisher","first-page":"1031","DOI":"10.1634\/theoncologist.2019-0285","volume":"24","author":"L Zheng","year":"2019","unstructured":"Zheng\u00a0L, Wang\u00a0Y, Xu\u00a0Z, Yang\u00a0Q, Zhu\u00a0G, Liao\u00a0XY, Chen\u00a0X, Zhu\u00a0B, Duan\u00a0Y, Sun\u00a0J (2019) Concurrent EGFR-TKI and thoracic radiotherapy as first-line treatment for stage IV non-small cell lung cancer harboring EGFR active mutations. Oncologist 24(8):1031\u2013e612. https:\/\/doi.org\/10.1634\/theoncologist.2019-0285","journal-title":"Oncologist"},{"issue":"2","key":"2042_CR24","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1016\/S1470-2045(14)71181-7","volume":"16","author":"A Thomas","year":"2015","unstructured":"Thomas\u00a0A, Rajan\u00a0A, Berman\u00a0A, Tomita\u00a0Y, Brzezniak\u00a0C, Lee\u00a0MJ, Lee\u00a0S, Ling\u00a0A, Spittler\u00a0AJ, Carter\u00a0CA, Guha\u00a0U, Wang\u00a0Y, Szabo\u00a0E, Meltzer\u00a0P, Steinberg\u00a0SM, Trepel\u00a0JB, Loehrer\u00a0PJ, Giaccone\u00a0G (2015) Sunitinib in patients with chemotherapy-refractory thymoma and thymic carcinoma: an open-label phase 2 trial. Lancet Oncol 16(2):177\u2013186. https:\/\/doi.org\/10.1016\/S1470-2045(14)71181-7","journal-title":"Lancet Oncol"},{"issue":"6","key":"2042_CR25","doi-asserted-by":"publisher","first-page":"843","DOI":"10.1016\/S1470-2045(20)30162-5","volume":"21","author":"J Sato","year":"2020","unstructured":"Sato\u00a0J, Satouchi\u00a0M, Itoh\u00a0S, Okuma\u00a0Y, Niho\u00a0S, Mizugaki\u00a0H, Murakami\u00a0H, Fujisaka\u00a0Y, Kozuki\u00a0T, Nakamura\u00a0K, Nagasaka\u00a0Y, Kawasaki\u00a0M, Yamada\u00a0T, Machida\u00a0R, Kuchiba\u00a0A, Ohe\u00a0Y, Yamamoto\u00a0N (2020) Lenvatinib in patients with advanced or metastatic thymic carcinoma (REMORA): a\u00a0multicentre, phase 2 trial. Lancet Oncol 21(6):843\u2013850. https:\/\/doi.org\/10.1016\/S1470-2045(20)30162-5","journal-title":"Lancet Oncol"},{"issue":"3","key":"2042_CR26","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1016\/S1470-2045(18)30062-7","volume":"19","author":"G Giaccone","year":"2018","unstructured":"Giaccone\u00a0G, Kim\u00a0C, Thompson\u00a0J, McGuire\u00a0C, Kallakury\u00a0B, Chahine\u00a0JJ, Manning\u00a0M, Mogg\u00a0R, Blumenschein\u00a0WM, Tan\u00a0MT, Subramaniam\u00a0DS, Liu\u00a0SV, Kaplan\u00a0IM, McCutcheon\u00a0JN (2018) Pembrolizumab in patients with thymic carcinoma: a\u00a0single-arm, single-centre, phase 2\u00a0study. Lancet Oncol 19(3):347\u2013355. https:\/\/doi.org\/10.1016\/S1470-2045(18)30062-7","journal-title":"Lancet Oncol"},{"issue":"1","key":"2042_CR27","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1007\/s00262-013-1474-y","volume":"63","author":"B Frey","year":"2014","unstructured":"Frey\u00a0B, Rubner\u00a0Y, Kulzer\u00a0L, Werthm\u00f6ller\u00a0N, Weiss\u00a0EM, Fietkau\u00a0R, Gaipl\u00a0US (2014) Antitumor immune responses induced by ionizing irradiation and further immune stimulation. Cancer Immunol Immunother 63(1):29\u201336. https:\/\/doi.org\/10.1007\/s00262-013-1474-y","journal-title":"Cancer Immunol Immunother"},{"issue":"21","key":"2042_CR28","doi-asserted-by":"publisher","first-page":"5254","DOI":"10.3390\/cancers13215254","volume":"13","author":"M Chiappetta","year":"2021","unstructured":"Chiappetta\u00a0M, Lococo\u00a0F, Pogliani\u00a0L, Sperduti\u00a0I, Tabacco\u00a0D, Bria\u00a0E, D\u2019Argento\u00a0E, Massaccesi\u00a0M, Boldrini\u00a0L, Meacci\u00a0E, Porziella\u00a0V, Nachira\u00a0D, Congedo\u00a0MT, Margaritora\u00a0S (2021) Masaoka-Koga and TNM staging system in thymic epithelial tumors: Prognostic comparison and the role of the number of involved structures. Cancers 13(21):5254. https:\/\/doi.org\/10.3390\/cancers13215254","journal-title":"Cancers"},{"issue":"11","key":"2042_CR29","doi-asserted-by":"publisher","first-page":"1642","DOI":"10.1097\/JTO.0000000000000660","volume":"10","author":"B Weksler","year":"2015","unstructured":"Weksler\u00a0B, Holden\u00a0A, Sullivan\u00a0JL (2015) Impact of positive nodal metastases in patients with thymic carcinoma and thymic neuroendocrine tumors. J\u00a0Thorac Oncol 10(11):1642\u20131647. https:\/\/doi.org\/10.1097\/JTO.0000000000000660","journal-title":"J Thorac Oncol"}],"container-title":["Strahlentherapie und Onkologie"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00066-022-02042-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00066-022-02042-w\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00066-022-02042-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,2,17]],"date-time":"2023-02-17T18:39:51Z","timestamp":1676659191000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00066-022-02042-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,2,2]]},"references-count":29,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2023,3]]}},"alternative-id":["2042"],"URL":"https:\/\/doi.org\/10.1007\/s00066-022-02042-w","relation":{},"ISSN":["0179-7158","1439-099X"],"issn-type":[{"value":"0179-7158","type":"print"},{"value":"1439-099X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,2,2]]},"assertion":[{"value":"16 August 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 December 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 February 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"J.\u00a0Jin, Y.\u00a0Hao, W.\u00a0Wang, S.\u00a0Wu, P.\u00a0Yue and Z.\u00a0Song declare that they have no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"The study was approved by Ethical Committee of Zhejiang Cancer Hospital (approval number: IRB-2022-343). The study has been granted an exemption from requiring written informed consent by the Ethical Committee of Zhejiang Cancer Hospital.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical standards"}}]}}